Genomic medicine innovations are no longer a futuristic concept; they are the bedrock of modern clinical diagnostics and personalized therapy. As we transition from a "one-size-fits-all" medical model to precision-based interventions, the role of high-precision manufacturers and suppliers becomes paramount. Shenzhen BioX Medical Co., Ltd. stands at the forefront of this revolution, bridging the gap between complex biotechnology and scalable clinical application.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing. With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
Large-scale genomic initiatives require modular, automated systems that reduce manual labor and minimize human error. Our solutions prioritize high-throughput capabilities for national health registries.
Suppliers must ensure 99.9% accuracy in nucleic acid detection and variant calling. We utilize advanced biomarker analysis equipment to meet the most stringent clinical thresholds.
Global procurement teams now prioritize OEM/ODM partners who offer localized support and consistent spare part availability to prevent diagnostic downtime.
Our product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
From Oncology profiling to Rare Disease screening, our macro-industry solutions are tailored to the "Quadruple Aim" of healthcare: improving patient experience, improving population health, reducing costs, and improving the work life of healthcare providers.
Moving from manual PCR to fully automated Sample-to-Result systems like the Sy-W7000, reducing the "hands-on" time from hours to minutes.
Integration of Machine Learning algorithms to assist clinicians in interpreting complex NGS data, identifying pathogenic variants with higher confidence scores.
Miniaturization of sequencing platforms for Point-of-Care (POC) applications, allowing genomic medicine to reach remote areas and bedside diagnostics.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. We recognize that genomic medicine is heavily regulated. Therefore, our commitment extends beyond manufacturing to encompass rigorous compliance with global standards including CE-IVD, ISO 13485, and FDA-registered facility protocols.
We provide full documentation support for local product registration and medical device licensing in all target markets.
On-site and remote training for laboratory staff to ensure optimal utilization of automated sequencing and PCR platforms.
Customized diagnostic solutions for distributors seeking to build their own brand within the precision medicine landscape.
We employ a multi-layered quality control system that includes raw material inspection, real-time stress testing of electronic components, and clinical verification of all PCR and sequencing kits before shipment.
Yes, our Eosbot Seq24 and Sy-W7000 systems are designed for high-throughput laboratory environments, making them ideal for national health screenings and large-scale genetic research initiatives.
We offer 24/7 technical support, remote diagnostic troubleshooting, and a global logistics network for rapid spare parts replacement.
Absolutely. Our R&D team works closely with research institutions to develop custom assays and modified hardware configurations through our OEM/ODM service department.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine. As a trusted genomic medicine innovation manufacturer, we welcome global partners to join us in shaping the future of healthcare.
BioX Medical
